Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20193704rdf:typepubmed:Citationlld:pubmed
pubmed-article:20193704lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:20193704lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:20193704lifeskim:mentionsumls-concept:C0312853lld:lifeskim
pubmed-article:20193704lifeskim:mentionsumls-concept:C2935387lld:lifeskim
pubmed-article:20193704pubmed:issue7lld:pubmed
pubmed-article:20193704pubmed:dateCreated2010-4-19lld:pubmed
pubmed-article:20193704pubmed:abstractTextTo address whether saccharide moieties of blood groups A, B and O antigens modulate hemolytic activity of Naja naja atra cardiotoxins (CTXs), the present study was carried out. Unlike other CTX isotoxins, hemolytic activity of CTX3 toward blood group O cholesterol-depleted red blood cells (RBCs) was notably lower than that of blood groups A and B cholesterol-depleted RBCs. Conversion of blood group B RBCs into blood group O RBCs by alpha-galactosidase treatment attenuated the susceptibility for hemolytic activity of CTX3, suggesting that H-antigen affected hemolytic potency of CTX3. Pre-incubation with H-trisaccharide reduced hemolytic activity and membrane-damaging activity of CTX3. Moreover, CTX3 showed a higher binding capability with H-trisaccharide than other CTXs did. CD spectra showed that the binding with H-trisaccharide induced changes in gross conformation of CTX3. Self-quenching studies revealed that oligomerization of CTX3 was affected in the presence of H-trisaccharide. Taken together, our data suggest that the binding of CTX3 with H-antigen alters its membrane-bound mode, thus reducing its hemolytic activity toward blood group O cholesterol-depleted RBCs.lld:pubmed
pubmed-article:20193704pubmed:languageenglld:pubmed
pubmed-article:20193704pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:citationSubsetIMlld:pubmed
pubmed-article:20193704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193704pubmed:statusMEDLINElld:pubmed
pubmed-article:20193704pubmed:monthJunlld:pubmed
pubmed-article:20193704pubmed:issn1879-3150lld:pubmed
pubmed-article:20193704pubmed:authorpubmed-author:LinShinne-Ren...lld:pubmed
pubmed-article:20193704pubmed:authorpubmed-author:ChangLong-Sen...lld:pubmed
pubmed-article:20193704pubmed:authorpubmed-author:KaoPei-HsiuPHlld:pubmed
pubmed-article:20193704pubmed:copyrightInfo2010 Elsevier Ltd. All rights reserved.lld:pubmed
pubmed-article:20193704pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20193704pubmed:day15lld:pubmed
pubmed-article:20193704pubmed:volume55lld:pubmed
pubmed-article:20193704pubmed:ownerNLMlld:pubmed
pubmed-article:20193704pubmed:authorsCompleteYlld:pubmed
pubmed-article:20193704pubmed:pagination1387-95lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:meshHeadingpubmed-meshheading:20193704...lld:pubmed
pubmed-article:20193704pubmed:year2010lld:pubmed
pubmed-article:20193704pubmed:articleTitleInteraction of Naja naja atra cardiotoxin 3 with H-trisaccharide modulates its hemolytic activity and membrane-damaging activity.lld:pubmed
pubmed-article:20193704pubmed:affiliationInstitute of Biomedical Sciences, National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.lld:pubmed
pubmed-article:20193704pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20193704pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:20193704pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed